APVO Earnings Aptevo Therapeutics Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–28 of 28
| Q2 2026 | 2026-06-30 | -5.31 | 2026-08-14 | 10-Q |
| Q1 2026 | 2026-03-31 | -6.41 | 2026-05-13 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 1685.97 | 2026-03-26 | 10-K |
| FY 2025 | 2025-12-31 | -87.27 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -40.14 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -151.29 | 2025-08-11 | 10-Q |
| Q1 2025 | 2025-03-31 | -1581.81 | 2025-05-15 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -23413.58 | 2025-02-14 | 10-K |
| FY 2024 | 2024-12-31 | -31460.23 | 2025-02-14 | 10-K |
| Q3 2024 | 2024-09-30 | -6441.48 | 2024-11-07 | 10-Q |
| Q2 2024 | 2024-06-30 | -1236.96 | 2024-08-08 | 10-Q |
| Q1 2024 | 2024-03-31 | -368.21 | 2024-05-08 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -1881.38 | 2024-03-05 | 10-K |
| FY 2023 | 2023-12-31 | -2316.83 | 2024-03-05 | 10-K |
| Q3 2023 | 2023-09-30 | -398.88 | 2023-11-14 | 10-Q |
| Q2 2023 | 2023-06-30 | -53.95 | 2023-08-10 | 10-Q |
| Q1 2023 | 2023-03-31 | 17.38 | 2023-05-11 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | 24.54 | 2023-03-30 | 10-K |
| FY 2022 | 2022-12-31 | 1.57 | 2023-03-30 | 10-K |
| Q3 2022 | 2022-09-30 | -27.00 | 2022-11-10 | 10-Q |
| Q2 2022 | 2022-06-30 | 5.58 | 2022-08-11 | 10-Q |
| Q1 2022 | 2022-03-31 | -1.55 | — | — |
| FY 2021 | 2021-12-31 | -6.07 | — | — |
| Q3 2021 | 2021-09-30 | -25.74 | — | — |
| Q2 2021 | 2021-06-30 | -1.75 | — | — |
| Q3 2018 | 2018-09-30 | -0.56 | 2018-11-14 | 10-Q |
| Q3 2017 | 2017-09-30 | 1.75 | 2017-11-13 | 10-Q |
| Q3 2016 | 2016-09-30 | -3.55 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.